Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Nephrol. 2002 Jul;58(1):63-7.

Epsilon-aminocaproic acid and renal complications: case report and review of the literature.

Author information

1
Department of Medicine, New England Medical Center, Boston, MA 02111, USA.

Abstract

Epsilon-aminocaproic acid (EACA) is a potent anti-fibrinolytic agent that is used in the treatment of excessive bleeding resulting from a systemic fibrinolytic state. It can also be used to treat hematuria through its action on decreasing urinary fibrinolysis. A broad range of renal complications has been ascribed to EACA. Although they are rare, they may be life-threatening and should therefore be immediately recognized.

PMID:
12141409
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center